Clinical Trial

Reprieve System Pilot Study

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the study is to evaluate the use of the Reprieve System to decongest subjects with acute decompensated heart failure.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-15; most recent amendment 2026-02-03.
Trial Details
NCT Number NCT06272734
Lead Sponsor Reprieve Cardiovascular, Inc
Conditions Acute Decompensated Heart Failure
Enrollment 50 participants
Start Date 2024-01-23
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-05